Evidence map›Paper›PMID 39480097›Full record

ArticleApplied and environmental microbiology2024

Elevated incidence of infant botulism in a 17-county area of the Mid-Atlantic region in the United States, 2000-2019, including association with soil types.

Haydee A Dabritz, Ingrid K Friberg, Jessica R Payne, Camille Moreno-Gorrin, Kristy Lunquest, Deepam Thomas, Alexandra P Newman, Elizabeth A Negrón, Patrick J Drohan

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Haydee A DabritzInfant Botulism Treatment and Prevention Program (IBTPP), Center for Laboratory Sciences, Infectious Diseases Laboratories Division, California Department of Public Health, Richmond, California, USA.ORCID 0000-0002-3243-5733
Ingrid K FribergInfant Botulism Treatment and Prevention Program (IBTPP), Center for Laboratory Sciences, Infectious Diseases Laboratories Division, California Department of Public Health, Richmond, California, USA.
Jessica R PayneInfant Botulism Treatment and Prevention Program (IBTPP), Center for Laboratory Sciences, Infectious Diseases Laboratories Division, California Department of Public Health, Richmond, California, USA.
Camille Moreno-GorrinOffice of Infectious Disease Epidemiology, Delaware Department of Health and Social Services, Dover, Delaware, USA.
Kristy LunquestDivision of Infectious Disease Surveillance, Prevention and Health Promotion Administration, Maryland Department of Health, Baltimore, Maryland, USA.
Deepam ThomasCommunicable Disease Service, Infectious Disease Epidemiology, New Jersey Department of Health, Trenton, New Jersey, USA.
Alexandra P NewmanRegional Epidemiology and Investigations Program, New York State Department of Health, Albany, New York, USA.
Elizabeth A NegrónBureau of Epidemiology, Pennsylvania Department of Health, Harrisburg, Pennsylvania, USA.
Patrick J DrohanDepartment of Ecosystems Science and Management, Pennsylvania State University, University Park, Pennsylvania, USA.

Funding

Infant Botulism Treatment & Prevention Fund at the California Department of Public Health
6 · The paper itself

Abstract

We sought to identify counties in the northeastern United States where the incidence of infant botulism (IB) is elevated compared to the nationwide incidence and to assess associations with soil type at the case residence. IB cases were identified through the distribution of the orphan drug Human Botulism Immune Globulin Intravenous for treatment of IB by state and national surveillance systems and were subsequently confirmed by laboratory testing. IB incidence by county was calculated as the number of IB cases divided by the number of live births in the county from 2000 to 2019. Cases were spatially mapped and assigned to soil types using the US Department of Agriculture's online soils database. Possible association with soil type was evaluated with the Chi-squared test. We identified a rectangular area consisting of 17 contiguous counties in Delaware, Maryland, New Jersey, New York, and Pennsylvania, approximately 80 km by 250 km, in which the 20-year incidence of IB was nearly seven times greater than that of the remaining counties in those five states. Within this area, case residences were strongly associated with certain soil types ( IMPORTANCE: Infant botulism occurs more frequently in 17 counties within and adjacent to the Delaware and Raritan River watersheds. This study should alert physicians and pediatricians in the area to the higher likelihood of encountering cases of this otherwise rare disease that manifests with constipation, poor feeding, loss of head control, weak suck/cry, generalized weakness, and descending bilateral paralysis.

Indexed as

BotulismClostridium botulinumHumansIncidenceInfantInfant, NewbornMid-Atlantic RegionSoilSoil MicrobiologyUnited StatesSoilbotulinum toxinClostridium botulinumepidemiologyIce Ageincidenceinfant botulismMid-Atlantic United StatesPleistocenesoil types

Identifiers

PMID39480097
PMCPMC11577774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.